Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
InnovAge Holding Corp(INNV)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for INNV
10/02/2026: INNV (2-star) is currently NOT-A-BUY. Pass it for now.
InnovAge Holding Corp is a specialized healthcare provider that offers comprehensive PACE services to frail, dual-eligible seniors. The company maintains a niche focus on value-based care, aiming to help patients age in place. While the company benefits from an aging demographic and government-backed funding, it faces significant risks related to regulatory compliance, operational execution, and heavy dependency on Medicare/Medicaid reimbursement rates. Recent years have seen the company shift from aggressive expansion toward internal stabilization. This stock is best suited for growth-oriented investors who can tolerate high volatility and regulatory risk, while monitoring the company's progress in restoring stable, consistent clinical and financial performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company serves a growing demographic but faces significant regulatory and operational execution hurdles. |
| Momentum investor | Weak fit | The stock lacks sustained upward momentum required for this style. |
| Value investor | Mixed fit | Valuation may appear attractive following volatility, but fundamental stability remains under assessment. |
| Dividend investor | Weak fit | The company does not pay a dividend and is in a growth/reinvestment phase. |
| Low-risk investor | Weak fit | Regulatory risks and historical operational volatility make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock has experienced significant price swings related to operational and regulatory updates. |
| Valuation risk | Medium | The market valuation is highly sensitive to the company's ability to demonstrate stable growth. |
| Competition risk (PACE and Home Health) | Medium / high | Large incumbents with better resources compete for the same dual-eligible senior patient pool. |
| Business quality | Medium | The business model provides essential care but carries high operational complexity and regulatory sensitivity. |
| Dividend income | Low / none | Investors receive no income, increasing reliance on capital appreciation. |
| Execution risk | High | Management must demonstrate the ability to scale centers while maintaining clinical and regulatory compliance. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 76.14% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  5.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.22B USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 639.2K shares | Beta 0.39 | 52 Weeks Range 3.94 - 12.64 | Updated Date 10/02/2026 |
52 Weeks Range 3.94 - 12.64 | Updated Date 10/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.02 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| PACE Capitation | Monthly payments from Medicare and Medicaid for managing the total care of enrolled frail seniors. | InnovAge receives a set fee per patient to manage their care; if they manage costs well, they keep the profit. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-09-08 | When After Market | Estimate 0.09 | Actual 0.06 |
Profitability
Profit Margin -0.26% | Operating Margin (TTM) 5.04% |
Management Effectiveness
Return on Assets (TTM) 0.67% | Return on Equity (TTM) -0.26% |
Valuation
Trailing PE - | Forward PE 13.66 | Enterprise Value 1.17B | Price to Sales(TTM) 1.24 |
Enterprise Value 1.17B | Price to Sales(TTM) 1.24 | ||
Enterprise Value to Revenue 1.19 | Enterprise Value to EBITDA 45.73 | Shares Outstanding 136.45M | Shares Floating 32.40M |
Shares Outstanding 136.45M | Shares Floating 32.40M | ||
Percent Insiders 61.29 | Percent Institutions 14.89 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About InnovAge Holding Corp
Exchange NASDAQ | Headquarters Denver, CO, United States | ||
IPO Launch date 2021-03-04 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 2500 | Website https://www.innovage.com |
Full time employees 2500 | Website https://www.innovage.com | ||
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.